About this trial
The aim of the study is to compare the effectiveness of Complete Decongestive Therapy and Non-Pneumatic Compression Therapy, both combined with routine physical therapy, in reducing pain and edema volume, improving range of motion, respiratory function, inflammatory markers, and overall quality of life in patients with post-mastectomy lymphedema.
Eligibility criteria
Qualifiers
Females with age between 30 to 60 years. (Monticciolo et al., 2021)
Females with unilateral mastectomy post three months of surgery. (Shen et al., 2023) 21
A volume difference to the circumferential measurements between the affected and unaffected upper extremities of more volume difference>10%.
Completed chemotherapy and/or radiation therapy. (Borman, Yaman, Yasrebi, İnanlı, & Dönmez, 2022)
Disqualifiers
Systemic disorders that might contraindicate the use of sequential compression therapy i.e. chronic kidney disease with renal failure, Congestive heart failure, neurological disorders, respiratory disorders.
Presence of active cellulitis, open and partially healed wounds.
Patients with lipedema
Active or recurrent cancer (defined as < 3 months since completion of cancer therapy)
Trial design
Treatments tested in this trial
- Non Pneumatic compression device
- Complete Decongestive therapy
Treatment groups
Sponsors and collaborators
Lahore University of Biological and Applied Sciences
Lead sponsor
University of Lahore
Collaborator